Longevity Protocol with Chronic Pain

How Chronic Pain Accelerates Aging

Chronic pain is more than a symptom. It disrupts sleep, reduces physical activity (the most powerful longevity intervention), affects mood and often brings long-term medication use with its own risks. In the US, 20.4 percent of adults have chronic pain and 8 percent have pain that limits daily life or work.¹

People with chronic pain have higher rates of cardiovascular disease, metabolic problems and depression, although much of that may reflect inactivity, poor sleep and medication effects rather than pain itself. Fibromyalgia involves central sensitization, in which the nervous system amplifies pain signals.

The longevity challenge of chronic pain is unique: the most powerful longevity intervention (exercise) is the one that pain makes most difficult. The protocol must be designed to work within pain's constraints while progressively expanding capacity.

Exercise: The Evidence-Based Approach to Movement with Pain

Modern pain science has replaced the old rest-and-protect model. A Cochrane overview found that exercise improves pain and physical function in chronic pain with small to moderate effects, and no evidence of harm.²

Start where you are. If your current tolerance is 5 minutes of walking, start there and build gradually, for example by about 10 percent a week. Consistency matters more than intensity. Pool walking and gentle swimming reduce joint load while you build tolerance.

Resistance training is essential. Muscle weakness can perpetuate pain cycles, and strength training is part of the exercise programs that improve pain and function.² Start with bodyweight or bands and progress as tolerance allows, two to three times a week.

Aerobic exercise as tolerated — Walking, cycling, swimming or an elliptical at a conversational pace, building toward 150 minutes a week.

Mind-body approaches — In a randomized trial in fibromyalgia, tai chi produced similar or greater improvement in symptoms than aerobic exercise, the standard exercise treatment.³ Yoga and mindfulness-based movement are reasonable alternatives.

Sleep, Stress, and Pain Neuroscience

Sleep is the highest priority. Chronic pain and insomnia feed each other: pain disrupts sleep, and poor sleep amplifies pain. CBT-I (cognitive behavioral therapy for insomnia) is first-line. If medication is needed, discuss the options with your provider; each has trade-offs, and some carry a risk of dependence or misuse.

Pain neuroscience education. Understanding that chronic pain often involves central sensitization — where the nervous system amplifies pain signals beyond tissue damage — changes the relationship with pain and improves outcomes. "Hurt does not equal harm" is a scientifically supported principle for most chronic pain conditions.

Stress management. Pain and stress share neural circuitry, and chronic stress can amplify sensitization. Mindfulness-based stress reduction, meditation and slow breathing are low-risk ways to turn the volume down.

Medication Considerations for Longevity

Minimize chronic NSAID use. In a meta-analysis of randomized trials, high-dose coxibs and diclofenac raised major vascular events by about a third, high-dose ibuprofen raised major coronary events, and naproxen did not significantly increase major vascular events; all regimens increased upper gastrointestinal complications.⁴ Use the lowest effective dose for the shortest time; topical NSAIDs such as diclofenac gel give local relief with minimal systemic exposure.

Opioid considerations. Long-term opioid use has been linked to hormonal suppression, disrupted sleep and paradoxically increased pain sensitivity. In a large cohort of patients with chronic noncancer pain, long-acting opioids were associated with 64 percent higher all-cause mortality than alternative pain medicines, mostly from deaths outside hospital.⁵ Work with your pain provider to minimize opioid use through multimodal approaches.

Duloxetine (Cymbalta) — A Cochrane review found moderate-quality evidence that 60 to 120 mg a day relieves pain in diabetic neuropathy and lower-quality evidence for fibromyalgia.⁶ It can also help coexisting depression or anxiety.

Low-dose naltrexone (LDN) — The evidence is mixed: a small trial reported more pain reduction than placebo (29 versus 18 percent),⁷ but a 2023 randomized trial found no clinically relevant pain relief in fibromyalgia.⁸ It is prescribed off-label through compounding pharmacies.

Supplements with Pain-Specific Evidence

Omega-3 fatty acids — In a meta-analysis of trials in inflammatory joint pain, omega-3s reduced patient-reported pain, morning stiffness and NSAID use.⁹ Evidence for other chronic pain conditions is limited.

Curcumin — In a randomized trial in knee osteoarthritis, a turmeric extract was non-inferior to ibuprofen for pain and function at four weeks.¹⁰ Long-term data are limited; check interactions if you take blood thinners.

Magnesium — Reasonable if your intake is low, and it may help sleep; claims that particular forms reach the brain are not established.

Vitamin D — Correct a deficiency, but don't expect pain relief: a Cochrane review concluded that a large benefit of vitamin D across chronic painful conditions is unlikely.¹¹

PEA (palmitoylethanolamide) — A meta-analysis of 11 studies (774 patients) found lower pain scores than comparators and no major side effects;¹² the studies were small, so treat it as promising rather than proven.

Creatine — In a randomized trial in fibromyalgia, creatine improved muscle strength and function but not pain, sleep or quality of life.¹³ Its value is supporting strength training.